In this webcast, you will learn how to secure your role as an EU compliance professional. Discover the essential steps to earning the RAPS Regulatory Compliance Certification.
The Regulatory Compliance Certification (RCC) is the industry standard for validating specialized regulatory expertise. Specifically, the RCC-MDR and RCC-IVDR are professional certifications — not training courses — that objectively confirm your proven knowledge and relevance. To earn the credential, you must meet eligibility criteria, pass a comprehensive exam, and maintain currency via ongoing professional development.
Why is the RCC necessary?
EU MDR and EU IVDR regulations mandate that manufacturers designate a Person Responsible for Regulatory Compliance (PRRC). Organizations worldwide urgently require qualified professionals with current, verified expertise for this mission-critical role.
The RCC addresses this need by providing objective, third-party evidence of your deep expertise, including at least four years of directly-related regulatory experience (or equivalent).
Why choose the RCC?
The RCC is the only professional certification specifically designed to validate expertise in EU MDR (RCC-MDR) or IVDR (RCC-IVDR). It is recognized as the industry standard for confirming you:
Why attend this webinar?
Join RAPS for this free, essential session to learn how earning an RCC certification can significantly bolster your qualifications to meet industry requirements as a trusted, verified PRRC professional.
You will leave this session prepared to:
The new RCC credentials are intended for individuals who need or want to demonstrate that they are compliance professionals who are knowledgeable in EU Medical Device (MDR) or In Vitro Diagnostics (IVDR) regulations. Four years of related experience or the equivalent is required to sit for the exam.
Basic: Content is introductory in nature and requires no requisite knowledge or experience to grasp concepts and related exercises. Basic educational activities are meant to establish a foundation of knowledge and/or competence that will be expanded upon in practice or in higher level activities.
Contact the RAPS Support Center:
Call +1 301 770 2920, ext. 200 (8:30 am–5:30 pm EST, Monday–Friday) or email [email protected].

Director, Precision Medicine & Digital Health - Global Regulatory Affairs

Director, Precision Medicine & Digital Health - Global Regulatory Affairs
Dr Conway has over 20 years of regulatory affairs and quality assurance experience, primarily within In Vitro Diagnostic (IVD) medical devices. Dr Conway joined GSK in Nov-2024 as Director, Global RA, Precision Medicine. Prior to joining GSK, she was a consultant (Aug 2022-Nov 2024) and previously the Head of IVD Notified Body (NB) at BSI Notified Body where she was pivotal in the implementation of the IVD Regulation (IVDR, (EU) 2017/246) and the successful designations of both the UK and the Netherlands organizations to the IVDR. Dr Conway represented IVD Notified Bodies on behalf of Team NB/NBCG-Med at MDCG IVD Working group meetings, where she contributed to the development of IVD MDCG guidance, as well as representing NBs in meetings for the development of the Companion Diagnostics consultation process as well as meetings with agency stakeholders on procedures for Class D IVDs under IVDR.
Dr Conway’s industrial experience started in the regulation of pharmaceuticals before moving into clinical trials for medicinal products for a CRO. Dr Conway moved into the field of IVD medical devices for a diagnostics company before becoming an independent consultant, working within the IVD and medical device fields. Dr Conway joined BSI in 2014 as a Technical Specialist/Scheme Manager in the IVD medical devices team before assuming the role of Global Head of the IVD Team in 2016, leading the IVD Technical team for operational delivery of Technical Documentation assessments and expanding the team to meet the increased resource demands under the IVDR. Her role also included independent final decision making. Dr Conway moved into the position of Head of IVD NB, where she was responsible for the overall compliance of the NB (and UKAB) for certification of IVDs. Dr Conway joined GSK in Nov 2024 to bring her experience into the field of precision medicine.